4.6 Article

Effect of patient- and center-level characteristics on uptake of home dialysis in Australia and New Zealand: a multicenter registry analysis

Journal

NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume 35, Issue 11, Pages 1938-1949

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/ndt/gfaa002

Keywords

center effects; home dialysis; home hemodialysis; peritoneal dialysis; practice patterns

Funding

  1. Centre Hospitalier de l'Universite de Montreal (CHUM)
  2. Fondation du CHUM
  3. Early Career Fellowship grant from the National Health and Medical Research Council (NHMRC)
  4. Jacquot Research Establishment Fellowship Award
  5. Princess Alexandra Research Foundation
  6. Fonds de recherche du Quebec-Sante

Ask authors/readers for more resources

Background. Home-based dialysis therapies, home hemodialysis (HHD) and peritoneal dialysis (PD) are underutilized in many countries and significant variation in the uptake of home dialysis exists across dialysis centers. This study aimed to evaluate the patient- and center-level characteristics associated with uptake of home dialysis. Methods. The Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry was used to include incident dialysis patients in Australia and New Zealand from 1997 to 2017. Uptake of home dialysis was defined as any HHD or PD treatment reported to ANZDATA within 6 months of dialysis initiation. Characteristics associated with home dialysis uptake were evaluated using mixed effects logistic regression models with patient- and center-level covariates, era as a fixed effect and dialysis center as a random effect. Results. Overall, 54 773 patients were included. Uptake of home-based dialysis was reported in 24 399 (45%) patients but varied between 0 and 87% across the 76 centers. Patient-level factors associated with lower uptake included male sex, ethnicity (particularly indigenous peoples), older age, presence of comorbidities, late referral to a nephrology service, remote residence and obesity. Center-level predictors of lower uptake included small center size, smaller proportion of patients with permanent access at dialysis initiation and lower weekly facility hemodialysis hours. The variation in odds of home dialysis uptake across centers increased by 3% after adjusting for the era and patient-level characteristics but decreased by 24% after adjusting for center-level characteristics. Conclusion. Center-specific factors are associated with the variation in uptake of home dialysis across centers in Australia and New Zealand.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Transplantation

Effect of lanthanum carbonate on serum calciprotein particles in patients with stage 3-4 CKD-results from a placebo-controlled randomized trial

Mark K. Tiong, Edward R. Smith, Elaine M. Pascoe, Grahame J. Elder, Nicole M. Lioufas, Eugenia Pedagogos, Carmel M. Hawley, Andrea Valks, Stephen G. Holt, Tim D. Hewitson, Nigel D. Toussaint

Summary: This study investigated the impact of lanthanum carbonate on serum calciprotein particles (CPP) in patients with early-stage chronic kidney disease (CKD). The results suggest that lanthanum carbonate is not effective in reducing CPP levels at 96 weeks compared with placebo.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Article Urology & Nephrology

Associations, microbiology and outcomes of pre-training peritoneal dialysis-related peritonitis

Ashik Hayat, David W. Johnson, Carmel M. Hawley, Lauren R. Jaffrey, Usman Mahmood, Sarah Saw Yu Mon, Yeoungjee Cho

Summary: This study aimed to compare the associations, microbiologic profiles, and outcomes between pre-training peritonitis (PTP) and post-training peritonitis in patients with kidney failure. The results showed that PTP was closely associated with prior exit-site infection, often had culture-negative peritonitis, and was associated with worse outcomes of hemodialysis transfer or death.

PERITONEAL DIALYSIS INTERNATIONAL (2023)

Article Health Policy & Services

Evaluating data quality in the Australian and New Zealand dialysis and transplant registry using administrative hospital admission datasets and data-linkage

Dharmenaan Palamuthusingam, Elaine M. Pascoe, Carmel M. Hawley, David W. Johnson, Gishan Ratnayake, Stephen McDonald, Neil Boudville, Matthew Jose, Magid Fahim

Summary: This study assessed the concordance between comorbidities recorded in the Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry and those in state-based hospital admission datasets. The results showed that the accuracy of diabetes mellitus recording was the highest, while the accuracy of cerebrovascular disease recording was the lowest.

HEALTH INFORMATION MANAGEMENT JOURNAL (2023)

Article Urology & Nephrology

Sex Disparity in Cause-Specific and All-Cause Mortality Among Incident Dialysis Patients

Wai H. Lim, Jenny H. C. Chen, Kimberley Minas, David W. Johnson, Maleeka Ladhani, Esther Ooi, Neil Boudville, Carmel Hawley, Andrea K. Viecelli, Matthew Roberts, Kate Wyburn, Rachael Walker, Monique Borlace, Helen Pilmore, Christopher E. Davies, Charmaine E. Lok, Armando Teixeira-Pinto, Germaine Wong

Summary: This study investigates the cause-specific mortality rates between male and female dialysis patients in Australia and New Zealand from 1998 to 2018. It found that female patients had a higher risk of all-cause mortality in the first 5 years after dialysis initiation, primarily due to mortality from infections and dialysis withdrawals.

AMERICAN JOURNAL OF KIDNEY DISEASES (2023)

Article Urology & Nephrology

Cigarette smoking and adverse health outcomes in patients treated with maintenance dialysis

Sibel G. Bek, Simone Marschner, Kamal Sud, David W. Johnson, Clara K. Chow, Carmel Hawley, Helen Pilmore, Germaine Wong, Wai Lim, Vincent W. Lee

Summary: This study found that smoking is associated with increased rates of all-cause mortality, cardiovascular mortality, respiratory failure, chronic lung disease, and malignancy in dialysis patients. It also increases the risk of non-skin cancers, de novo vascular disease, and chronic lung disease.

NEPHROLOGY (2023)

Article Pediatrics

Baseline characteristics of participants in the NAVKIDS2 trial: a patient navigator program in children with chronic kidney disease

Chandana Guha, Rabia Khalid, Anita van Zwieten, Anna Francis, Carmel M. Hawley, Allison Jaure, Armando Teixeira-Pinto, Alistair R. Mallard, Amelie Bernier-Jean, David W. Johnson, Deirdre Hahn, Donna Reidlinger, Elaine M. Pascoe, Elizabeth G. Ryan, Fiona Mackie, Hugh J. McCarthy, Jonathan C. Craig, Julie Varghese, Charani Kiriwandeniya, Kirsten Howard, Nicholas G. Larkins, Luke Macauley, Amanda Walker, Martin Howell, Michelle Irving, Patrina H. Y. Caldwell, Reginald Woodleigh, Shilpanjali Jesudason, Simon A. Carter, Sean E. Kennedy, Stephen Alexander, Steven McTaggart, Germaine Wong

Summary: This study aims to evaluate the effectiveness of a patient navigator program in children with chronic kidney disease. A total of 162 patients were enrolled and randomized into immediate intervention and waitlisted groups. The results of the study will be completed by October 2022.

PEDIATRIC NEPHROLOGY (2023)

Review Urology & Nephrology

Range and consistency of gastrointestinal outcomes reported in peritoneal dialysis trials: A systematic review

Ashik Hayat, Rachael C. Walker, Andrea K. Viecelli, Karine E. Manera, Allison Jaure, Rathika Krishnasamy, Elaine M. Pascoe, Yeoungjee Cho, David W. Johnson

Summary: This study assessed the range and consistency of gastrointestinal (GI) outcomes reported in contemporary peritoneal dialysis (PD) trials. It found that only 19% of PD trials reported GI outcomes, with nausea, diarrhea, vomiting, constipation, and abdominal pain being the most frequently reported outcomes. The majority of GI outcomes were patient-reported adverse events with no defined metrics.

PERITONEAL DIALYSIS INTERNATIONAL (2023)

Article Urology & Nephrology

Incidence, Risk Factors, and Outcomes of Kidney Transplant Recipients With BK Polyomavirus-Associated Nephropathy

Ryan Gately, Elasma Milanzi, Wai Lim, Armando Teixeira-Pinto, Phil Clayton, Nicole Isbel, David W. Johnson, Carmel Hawley, Scott Campbell, Germaine Wong

Summary: BK polyomavirus-associated nephropathy (BKPyVAN) is associated with an increased risk of graft dysfunction and loss in kidney transplant recipients. This cohort study in Australia and New Zealand found that BKPyVAN occurred in 3% of recipients and was linked to higher rates of graft loss, rejection, and death. Changes in immunosuppression, such as reducing tacrolimus and mycophenolate doses, were commonly made after BKPyVAN. Several factors, including gender, age, blood group, donor characteristics, transplantation era, immunosuppression use, and transplant center volume, were associated with the development of BKPyVAN. The study also found that BKPyVAN increased the risk of graft loss but not mortality. It highlights the need for interventional trials to evaluate strategies for reducing immunosuppression and minimizing adverse outcomes associated with BKPyVAN.

KIDNEY INTERNATIONAL REPORTS (2023)

Article Urology & Nephrology

Australian Workshops on Patients' Perspectives on Hemodialysis and Incremental Start

Katharine Hegerty, Allison Jaure, Nicole Scholes-Robertson, Kirsten Howard, Angela Ju, Nicole Evangelidis, Martin Wolley, Amanda Baumgart, David W. Johnson, Carmel M. Hawley, Donna Reidlinger, Laura Hickey, Alyssa Welch, Yeoungjee Cho, Peter G. Kerr, Matthew A. Roberts, Jenny I. Shen, Jonathan Craig, Rathika Krishnasamy, Andrea K. Viecelli

Summary: This study aimed to explore patients' perspectives on incremental hemodialysis (HD) and their priorities and concerns regarding HD. The study found that patients with kidney failure preferred incremental initiation of HD to minimize disruption to daily living and improve quality of life. The top prioritized outcomes were quality of life, residual kidney function, and mortality.

KIDNEY INTERNATIONAL REPORTS (2023)

Review Transplantation

Range and Consistency of Cardiovascular Outcomes Reported by Clinical Trials in Kidney Transplant Recipients: A Systematic Review

Gregory J. Wilson, Kim Van, Emma O'Lone, Allison Tong, Jonathan C. Craig, Benedicte Sautenet, Klemens Budde, Derek Forfang, John Gill, William G. Herrington, Tazeen H. Jafar, David W. Johnson, Vera Krane, Adeera Levin, Jolanta Malyszko, Patrick Rossignol, Deirdre Sawinski, Nicole Scholes-Robertons, Giovanni Strippoli, Angela Wang, Wolfgang C. Winkelmayer, Carmel M. Hawley, Andrea K. Viecelli

Summary: This study aimed to assess the range and consistency of cardiovascular outcomes reported by contemporary trials in kidney transplant recipients, revealing substantial heterogeneity in cardiovascular outcome reporting.

TRANSPLANTATION DIRECT (2023)

Article Urology & Nephrology

Association of Incremental peritoneal dialysis with residual kidney function decline in patients on peritoneal dialysis: The balANZ trial

Ashik Hayat, Yeoungjee Cho, Carmel M. Hawley, Htay Htay, Rathika Krishnasamy, Elaine Pascoe, Isaac Teitelbaum, Marliene Varnfield, David W. Johnson

Summary: Comparing with full-dose PD start, incremental PD start shows similar declines in RKF and UV.

PERITONEAL DIALYSIS INTERNATIONAL (2023)

Article Urology & Nephrology

Peritoneal Dialysis-Related Infections

Yeoungjee Cho, Kai-Ming Chow, Philip Kam-Tao Li, Naomi Runnegar, David W. Johnson

Summary: Peritoneal dialysis is an important treatment option for patients with kidney failure, providing various benefits such as enhanced participation in daily activities, flexibility in schedules, cost savings, and improved quality of life. However, the utilization of peritoneal dialysis has remained static or declining in certain regions due to concerns about PD-related infections. This review aims to provide an overview of the definition, epidemiology, risk factors, prevention, and treatment of PD-related infections based on current evidence.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)

Article Urology & Nephrology

Oral vitamin D supplementation on the prevention of peritoneal dialysis-related peritonitis: A pilot randomised controlled trial

Yu-Hui Zhang, Xiao Xu, Hai-Chen Pi, Zhi-Kai Yang, David W. Johnson, Jie Dong

Summary: This study aimed to examine the effects of vitamin D supplementation on the risk of PD-related peritonitis. The results showed that oral natural vitamin D supplementation can increase serum 25(OH)D levels in PD patients, without affecting the occurrence or outcome of peritonitis. The study suggests that conducting this type of randomized controlled trial is feasible and safe.

PERITONEAL DIALYSIS INTERNATIONAL (2023)

No Data Available